Retraction Note To: Transient Activation of Reprogramming Transcription Factors Using Protein Transduction Facilitates Conversion of Human Fibroblasts Toward Cardiomyocyte-Like Cells (Molecular Biotechnology, (2017), 59, (207-220), 10.1007/S12033-017-0007-X)

Retraction Note To: Transient Activation of Reprogramming Transcription Factors Using Protein Transduction Facilitates Conversion of Human Fibroblasts Toward Cardiomyocyte-Like Cells (Molecular Biotechnology, (2017), 59, (207-220), 10.1007/S12033-017-0007-X) Publisher Pubmed

Ghazizadeh Z^{1, 2} ; Rassouli H³ ; Fonoudi H¹ ; Alikhani M³ ; Talkhabi M¹ ; Darbandiazar A⁴ ; Chen S⁵ ; Baharvand H^{1, 6} ; Aghdami N^{1, 7} ; Salekdeh GH³

Source: Molecular Biotechnology Published:2022

Abstract

In a mutual agreement between the editors and authors, the authors have retracted this Article [1]. Concerns were raised regarding Fig. 3B, specifically: • Part of the 'Nanog' and 'SSEA-4' panels appear to be unexpectedly similar. • Part 'TRA-1–60' and 'TRA-1–81' panels appear to be unexpectedly similar. All authors agree to this retraction. © Springer Science+Business Media, LLC, part of Springer Nature 2021.

Related Docs

View other Related Docs

1. Retraction Note: Codelivery of Hif-1Α Sirna and Dinaciclib by Carboxylated Graphene Oxide-Trimethyl Chitosan-Hyaluronate Nanoparticles Significantly Suppresses Cancer Cell Progression (Pharm Res, (2020), 37, (196), 10.1007/S11095-020-02892-Y), Pharmaceutical Research (2022)

2. Retraction Notice to “Inhibition of Cd73 Using Folate Targeted Nanoparticles Carrying Anti-Cd73 Sirna Potentiates Anticancer Efficacy of Dinaciclib” [Life Sci. 259 (2020) 118150] (Life Sciences (2020) 259, (S0024320520309024), (10.1016/J.Lfs.2020.118150)), Life Sciences (2024)

3. Retraction Notice to “A Novel Biocompatible Drug Delivery System of Chitosan/Temozolomide Nanoparticles Loaded Pcl-Pu Nanofibers for Sustained Delivery of Temozolomide” [International Journal of Biological Macromolecules 97 (2017) 744–751, (S0141813016327489), (10.1016/J.Ijbiomac.2017.01.073)], International Journal of Biological Macromolecules (2025)

Experts (# of related papers)

View all Related Experts

Fatemeh Atyabi (3)

Alimohammad Alizadeh (1)

Style	Citing Format
MLA	Ghazizadeh Z, et al.. "Retraction Note To: Transient Activation of Reprogramming Transcription Factors Using Protein Transduction Facilitates Conversion of Human Fibroblasts Toward Cardiomyocyte-Like Cells (Molecular Biotechnology, (2017), 59, (207-220), 10.1007/S12033-017-0007-X)." Molecular Biotechnology, vol. 64, no. 1, 2022, pp. 108-.
APA	Ghazizadeh Z, Rassouli H, Fonoudi H, Alikhani M, Talkhabi M, Darbandiazar A, Chen S, Baharvand H, Aghdami N, Salekdeh GH (2022). Retraction Note To: Transient Activation of Reprogramming Transcription Factors Using Protein Transduction Facilitates Conversion of Human Fibroblasts Toward Cardiomyocyte-Like Cells (Molecular Biotechnology, (2017), 59, (207-220), 10.1007/S12033-017-0007-X). Molecular Biotechnology, 64(1), 108-.
Chicago	Ghazizadeh Z, Rassouli H, Fonoudi H, Alikhani M, Talkhabi M, Darbandiazar A, Chen S, Baharvand H, Aghdami N, Salekdeh GH. "Retraction Note To: Transient Activation of Reprogramming Transcription Factors Using Protein Transduction Facilitates Conversion of Human Fibroblasts Toward Cardiomyocyte-Like Cells (Molecular Biotechnology, (2017), 59, (207-220), 10.1007/S12033-017-0007-X)." Molecular Biotechnology 64, no. 1 (2022): 108-.
Harvard	Ghazizadeh Z et al. (2022) 'Retraction Note To: Transient Activation of Reprogramming Transcription Factors Using Protein Transduction Facilitates Conversion of Human Fibroblasts Toward Cardiomyocyte-Like Cells (Molecular Biotechnology, (2017), 59, (207-220), 10.1007/S12033-017-0007-X)', Molecular Biotechnology, 64(1), pp. 108-.
Vancouver	Ghazizadeh Z, Rassouli H, Fonoudi H, Alikhani M, Talkhabi M, Darbandiazar A, et al.. Retraction Note To: Transient Activation of Reprogramming Transcription Factors Using Protein Transduction Facilitates Conversion of Human Fibroblasts Toward Cardiomyocyte-Like Cells (Molecular Biotechnology, (2017), 59, (207-220), 10.1007/S12033-017-0007-X). Molecular Biotechnology. 2022;64(1):108-.
BibTex	@article{ author = {Ghazizadeh Z and Rassouli H and Fonoudi H and Alikhani M and Talkhabi M and Darbandiazar A and Chen S and Baharvand H and Aghdami N and Salekdeh GH}, title = {Retraction Note To: Transient Activation of Reprogramming Transcription Factors Using Protein Transduction Facilitates Conversion of Human Fibroblasts Toward Cardiomyocyte-Like Cells (Molecular Biotechnology, (2017), 59, (207-220), 10.1007/S12033-017-0007-X)}, journal = {Molecular Biotechnology}, volume = {64}, number = {1}, pages = {108-}, year = {2022} }
RIS	TY - JOUR AU - Ghazizadeh Z AU - Rassouli H AU - Fonoudi H AU - Alikhani M AU - Talkhabi M AU - Darbandiazar A AU - Chen S AU - Baharvand H AU - Aghdami N AU - Salekdeh GH TI - Retraction Note To: Transient Activation of Reprogramming Transcription Factors Using Protein Transduction Facilitates Conversion of Human Fibroblasts Toward Cardiomyocyte-Like Cells (Molecular Biotechnology, (2017), 59, (207-220), 10.1007/S12033-017-0007-X) JO - Molecular Biotechnology VL - 64 IS - 1 SP - 108 EP - PY - 2022 ER -

Style

Citing Format

MLA

Ghazizadeh Z, et al.. "Retraction Note To: Transient Activation of Reprogramming Transcription Factors Using Protein Transduction Facilitates Conversion of Human Fibroblasts Toward Cardiomyocyte-Like Cells (Molecular Biotechnology, (2017), 59, (207-220), 10.1007/S12033-017-0007-X)." Molecular Biotechnology, vol. 64, no. 1, 2022, pp. 108-.

APA

Ghazizadeh Z, Rassouli H, Fonoudi H, Alikhani M, Talkhabi M, Darbandiazar A, Chen S, Baharvand H, Aghdami N, Salekdeh GH (2022). Retraction Note To: Transient Activation of Reprogramming Transcription Factors Using Protein Transduction Facilitates Conversion of Human Fibroblasts Toward Cardiomyocyte-Like Cells (Molecular Biotechnology, (2017), 59, (207-220), 10.1007/S12033-017-0007-X). Molecular Biotechnology, 64(1), 108-.

Chicago

Ghazizadeh Z, Rassouli H, Fonoudi H, Alikhani M, Talkhabi M, Darbandiazar A, Chen S, Baharvand H, Aghdami N, Salekdeh GH. "Retraction Note To: Transient Activation of Reprogramming Transcription Factors Using Protein Transduction Facilitates Conversion of Human Fibroblasts Toward Cardiomyocyte-Like Cells (Molecular Biotechnology, (2017), 59, (207-220), 10.1007/S12033-017-0007-X)." Molecular Biotechnology 64, no. 1 (2022): 108-.

Harvard

Ghazizadeh Z et al. (2022) 'Retraction Note To: Transient Activation of Reprogramming Transcription Factors Using Protein Transduction Facilitates Conversion of Human Fibroblasts Toward Cardiomyocyte-Like Cells (Molecular Biotechnology, (2017), 59, (207-220), 10.1007/S12033-017-0007-X)', Molecular Biotechnology, 64(1), pp. 108-.

Vancouver

Ghazizadeh Z, Rassouli H, Fonoudi H, Alikhani M, Talkhabi M, Darbandiazar A, et al.. Retraction Note To: Transient Activation of Reprogramming Transcription Factors Using Protein Transduction Facilitates Conversion of Human Fibroblasts Toward Cardiomyocyte-Like Cells (Molecular Biotechnology, (2017), 59, (207-220), 10.1007/S12033-017-0007-X). Molecular Biotechnology. 2022;64(1):108-.

BibTex

@article{ author = {Ghazizadeh Z and Rassouli H and Fonoudi H and Alikhani M and Talkhabi M and Darbandiazar A and Chen S and Baharvand H and Aghdami N and Salekdeh GH}, title = {Retraction Note To: Transient Activation of Reprogramming Transcription Factors Using Protein Transduction Facilitates Conversion of Human Fibroblasts Toward Cardiomyocyte-Like Cells (Molecular Biotechnology, (2017), 59, (207-220), 10.1007/S12033-017-0007-X)}, journal = {Molecular Biotechnology}, volume = {64}, number = {1}, pages = {108-}, year = {2022} }

RIS

TY - JOUR
AU - Ghazizadeh Z
AU - Rassouli H
AU - Fonoudi H
AU - Alikhani M
AU - Talkhabi M
AU - Darbandiazar A
AU - Chen S
AU - Baharvand H
AU - Aghdami N
AU - Salekdeh GH
TI - Retraction Note To: Transient Activation of Reprogramming Transcription Factors Using Protein Transduction Facilitates Conversion of Human Fibroblasts Toward Cardiomyocyte-Like Cells (Molecular Biotechnology, (2017), 59, (207-220), 10.1007/S12033-017-0007-X)
JO - Molecular Biotechnology
VL - 64
IS - 1
SP - 108
EP -
PY - 2022
ER -

Science Communicator Platform

Authors

Abstract